A selection system to study C5a-C5a-receptor interactions: Phage display of a novel C5a anaphylatoxin, Fos-C5a(Ala27)

Gene

Volumn 184, Issue 2, 1997, Pages 263-272

  Hennecke, Meike ^a   Kola, Axel ^a   Baensch, Melanie ^a   Wrede, Annette ^a   Klos, Andreas ^a   Bautsch, Wilfried ^a   Köhl, Jörg ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

AT; Complement; Complement 5a; Inflammation

Indexed keywords

ALANINE; ANAPHYLATOXIN; BUTYRYL CYCLIC AMP; COMPLEMENT COMPONENT C5A; COMPLEMENT RECEPTOR; COMPLEMENTARY DNA; CYSTEINE; SYNTHETIC PEPTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL DIFFERENTIATION; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PHAGE DISPLAY; PHAGEMID; PLASMID; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS;

ALANINE; ANTIGENS, CD; BACTERIOPHAGES; BINDING, COMPETITIVE; CELL LINE; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; COMPLEMENT C5A; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; MUTATION; PEPTIDE LIBRARY; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RECOMBINANT FUSION PROTEINS;

EID: 0031013035     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(96)00611-7     Document Type: Article

References (61)

1. Barton, P.A. and Warren, J.S. (1993) Complement component C5 modulates the systemic tumor necrosis factor response in murine endotoxic shock. Infect. Immun. 61, 1474-1481.
2. Bautsch, W., Emde, M., Kretzschmar, T., Köhl, J., Suckau, D. and Bitter-Suermann, D. (1992) Human C5a anaphylatoxin: gene cloning and expression in Escherichia coli. Immunobiology 185, 41-52.
3. Björk, J., Hugli, T.E. and Smedegard, G. (1985) Microvascular effects of anaphylatoxins C3a and C5a. J. Immunol. 134, 1115-1119.
4. Bockaert, J. (1991) G proteins and G-protein-coupled receptors: structure, function and interactions. Curr. Opin. Neurobiol. 1, 32-42.
5. Bokisch, V.A. and Müller-Eberhard, H.J. (1970) Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J. Clin. Invest. 49, 2427-2436.
6. Bonilla-Argudo, V., Fieldhouse, J., Gimenez-Gallego, G., Springer, M. and Collier, K. (1987) Synthesis and secretion of recombinant C5a in Saccharomyces cerevisiae. Fed. Proc. Fed. Am. Soc. Exp. Biol. 46, 774-775.
7. Boulay, F., Mery, L., Tardif, M., Brouchon, L. and Vignaism, P. (1991) Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry 30, 2993-2999.
8. Bubeck, P., Grötzinger, J., Winkler, M., Kohl, J., Wollmer, A., Klos, A. and Bautsch, W. (1994) Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor. Eur. J. Biochem. 219, 897-904.
9. Burg, M., Martin, U., Rheinheimer, C., Köhl, J., Bautsch, W., Böttger, E.C. and Klos, A. (1995) IFN-gamma up-regulates the human C5a receptor (CD88) in myeloblastic U937 cells and related cell lines. J. Immunol. 155, 4419-4426.
10. Cai, X. and Garen, A. (1995) Anti-melanoma antibodies from melanoma patients immunized with genetically modified autologous tumour cells: selection of specific antibodies from single-chain Fv fusion phage libraries. Proc. Natl. Acad. Sci. USA 92, 6537-6541.
11. Cochrane, C.G. and Müller-Eberhard, J. (1968) The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. Exp. Med. 127, 371-386.
12. Collier, V., Bonilla-Argudo, V., Gimenez-Gallego, G., Fieldhouse, J., Kelder, B., Rollins, T., Siciliano, S., Springer, M. and Kopchik, J. (1987) Synthesis and secretion of recombinant C5a directed by plasmid clones encoding heterologous signal peptide sequences. Fed. Proc. Fed. Am. Soc. Exp. Biol. 46, 772-773.
13. Crameri, R. and Suter, M. (1993) Display of biologically active proteins on the surface of filamentous phages: a cDNA cloning system for selection of functional gene products linked to the genetic information responsible for their production. Gene 137, 69-75.
14. DeKruif, J., Terstappen, L., Boel, E. and Logtenberg, T. (1995) Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. USA 92, 3938-3942.
15. DeMartino, J.A., Konteatis, Z.D., Siciliano, S.J., Van Riper, G., Underwood, D.J., Fischer, P.A. and Springer, M.S. (1995) Arginine 206 of the C5a receptor is critical for ligand recognition and receptor activation by C-terminal hexapeptide analogs. J. Biol. Chem. 270, 15966-15969.
16. Doorbar, J. and Winter, G. (1994) Isolation of a peptide antagonist to the thrombin receptor using phage display. J. Mol. Biol. 244, 361-369.
17. Dower, W.J., Miller, J.F. and Ragsdale, C.W. (1988) High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 16, 6127-6145.
18. Ember, J.A., Sanderson, S.D., Taylor, S.M., Kawahara, M. and Hugli, T.E. (1992) Biologic activity of synthetic analogues of C5a anaphylatoxin. J. Immunol. 148, 3165-3173.
19. Ember, J.A., Sanderson, S.D., Hugli, T.E. and Morgan, E.L. (1994) Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. Am. J. Pathol. 144, 393-403.
20. Fernandez, H.N. and Hugli, T.E. (1976) Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a. J. Immunol. 117, 1688-1694.
21. Franke, A.E., Andrews, G.C., Stimler-Gerard, N.P., Gerard, C. and Showell, H.J. (1988) Human C5a anaphylatoxin: gene synthesis, expression, and recovery of biologically active material from Escherichia coli. Methods Enzymol. 162, 653-668.
22. Gasque, P., Chan, P., Fontaine, M., Ischenko, A., Lamacz, M., Götze, O. and Morgan, B.P. (1995) Identification and characterization of the complement C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155, 4882-4889.
23. Gentz, R., Rauscher III, F.J., Abate, C. and Curran, T. ( 1989) Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains. Science 243, 1695-1699.
24. Gerard, N.P., Hodges, M.K., Drazen, J.M., Weller, P.F. and Gerard C. (1989) Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J. Biol. Chem. 264, 1760-1766.
25. Gerard, N.P. and Gerard, C. (1990) Construction and expression of a novel recombinant anaphylatoxin, C5a-N19, as a probe for the human C5a receptor. Biochemistry 29, 9274-9281.
26. Gerard, N.P. and Gerard, C. (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-616.
27. Goldstein, I.M. (1988) Complement: biologically active products. In: Gallin, J.I., Goldstein, I.M. and Snyderman, R. (Eds.), Inflammation: Basic Principles and Clinical Correlates. Raven Press, New York, pp. 55-74.
28. Goldstein, I.M. and Weissmann, G. (1974) Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes. J. Immunol. 113, 1583-1588.
29. Goodson, R.J., Doyle, M.V., Kaufman, S.E. and Rosenberg, S. (1994) High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc. Natl. Acad. Sci. USA 91, 7129-7133.
30. Hartmann, H., Lübbers, B., Casaretto, M., Bautsch, W., Klos, A. and Kohl, J. (1993) Rapid quantification of C3a and C5a using a combination of Chromatographic and immunoassay procedures. J. Immunol. Methods 166, 35-44.
31. Haviland, D.L., McCoy, R.L., Whitehead, W.T., Akama, H., Molmenti, E.P., Brown, A., Haviland, J.C., Parks, W.C., Perlmutter, D.H. and Wetsel, R.A. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
32. Higuchi, R., Krummel, B. and Saiki, R.K. (1988) A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interaction. Nucleic Acids Res. 16, 7351-7367.
33. Huey, R., Fukuoka, Y., Hoeprich, P.D.J. and Hugli, T.E. ( 1986) Cellular receptors to the anaphylatoxins C3a and C5a. Biochem. Soc. Symp. 51, 69-81.
34. Johnson, R.J. and Chenoweth, D.E. (1985) Structure and function of human C5a anaphylatoxin. Selective modification of tyrosine 23 alters biological activity but not antigenicity. J. Biol. Chem. 260, 10339-10345.
35. Kaufmann, E., Geisler, N. and Weber, K. (1984) SDS-PAGE strongly overestimates the molecular masses of the neurofilament proteins. FEBS Lett. 170, 81-84.
36. Kawai, M., Quincy, D.A., Lane, B., Mollison, K.W., Luly, J.R. and Carter, G.W. (1991) Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. J. Med. Chem. 34, 2068-2071.
37. Kawai, M., Quincy, D.A., Lane, B., Mollison, K.W., Or, Y.S., Luly, J.R. and Carter, G.W. (1992) Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a. J. Med. Chem. 35, 220-223.
38. Klos, A., Ihrig, V., Messner, M., Grabbe, J. and Bitter-Suermann, D. (1988) Detection of native human complement components C3 and C5 and their primary activation peptides C3a and C5a (anaphylatoxin peptides) by ELISAs with monoclonal antibodies. J. Immunol. Methods 111, 241-252.
39. Klos, A., Bank, S., Gietz, C., Bautsch, W., Kohl, J., Burg, M. and Kretzschmar, T. (1992) C3a receptor on dibutyryl-cAMP-differentiated U937 cells and human neutrophils: the human C3a receptor characterized by functional responses and 125I-C3a binding. Biochemistry 31, 11274-11282.
40. Kohl, J. and Bitter-Suermann, D. (1993) Anaphylatoxins. In: Whaley, K., Loos, M. and Weiler, J.M. (Eds.), Complement in Health and Disease. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 297-324.
41. Köhl, J., Lübbers, B., Klos, A, Bautsch, W. and Casaretto, M. (1993) Evaluation of the C-terminal C5a effector site with short synthetic C5a analog peptides. Eur. J. Immunol. 23, 646-652.
42. Kola, A., Baensch, M., Bautsch, W., Hennecke, M., Klos, A., Casaretto, M. and Köhl, J. (1996) Epitope mapping of a C5a neutralizing mAb using a combinatorial approach of phage display, synthetic peptides and site directed mutagenesis. Immunotechnology 2, 115-126.
43. Mandecki, W., Mollison, K.W., Bolling, T.J., Powell, B.S., Carter, G.W. and Fox, J.L. (1985) Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli. Proc. Natl. Acad. Sci. USA 82, 3543-3547.
44. Marks, J.D., Ouwehand, W.H., Bye, J.M., Finnern, R., Gorick, B.D., Voak, D., Thorpe, S.J., Hughes-Jones, N.C. and Winter, G. (1993) Human antibody fragments specific for human blood group antigens from a phage display library. Bio/Technology 11, 1145-1149.
45. McCafferty, J., Griffiths, A.D., Winter, G. and Chiswell, D.J. (1990) Phage antibodies: filamentous phage displying antibody variable domains. Nature 348, 552-554.
46. Meuer, S., Zanker, B., Hadding, U. and Bitter-Suermann, D. (1982) Low zone desensitization: a stimulus-specific control mechanisms of cell response. Investigations on anaphylatoxin-induced platelet secretion. J. Exp. Med. 155, 698-710.
47. Meulemans, E.V., Slobbe, R., Wasterval, P., Ramaekers, F.C.S. and van Eys, G.J.J.M. (1994) Selection of phage-displayed antibodies specific for a cytoskeletal antigen by competitive elution with a monoclonal antibody. J. Mol. Biol. 244, 353-360.
48. Mollison, K.W., Mandecki, W., Zuiderweg, E.R., Fayer, L., Fey, T.A., Krause, R.A., Conway, R.G., Miller, L., Edalji, R.P., Shallcross, M.A. et al. (1989) Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 86, 292-296.
49. Mollison, K.W., Fey, T.A., Krause, R.A., Miller, L., Edalji, R.P., Conway, R.G., Mandecki, W., Shallcross, M.A., Kawai, M., Or, Y.S. et al. (1991) C5a structural requirements for neutrophil receptor interaction. Agents Actions Suppl. 35, 17-21.
50. Monk, P.N., Barker, M.D., Partridge, L.J. and Pease, J.E. (1995) Mutation of glutamate 199 of the human C5a receptor defines a binding site for ligand distinct from the receptor N terminus. J. Biol. Chem. 270, 16625-16629.
51. Munson, P.J. and Rodbard, D. (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
52. Okusawa, S., Dinarello, C.A., Yancey, K.B., Endres, S., Lawley, T.J., Frank, M.M., Burke, J.F. and Gelfand, J.A. (1987) C5a induction of human interleukin. 1. Synergistic effect with endotoxin or interferon-gamma. J. Immunol. 139, 2635-2640.
53. O'Neil, K.T., Hoess, R.H., Jackson, S.A., Ramachandran, N.S., Mousa, S.A. and DeGrado, W.F. (1992) Identification of a novel peptide antagonist for gpIIb/IIIa from a conformationally constrained phage peptide library. Proteins 14, 509-515.
54. Roberts, B.L., Markland, W., Ley, A.C., Kent, R.B., White, D.W., Guterman, S.K. and Ladner, R.C. (1992) Directed evolution of a protein: Selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. Proc. Natl. Acad. Sci. USA 89, 2429-2433.
55. Rollins, T.E. and Springer, M.S. (1985) Identification of the polymorphonuclear leukocyte C5a receptor. J. Biol. Chem. 260, 7157-7160.
56. Sacks, T., Moldow, C.F., Craddock, P.R., Bowers, T.K. and Jacob, H.S. (1978) Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest. 61, 1161-1167.
57. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning. A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
58. Scholz, W., McClurg, M.R., Cardenas, G.J., Smith, M., Noonan, D.J., Hugli, T.E. and Morgan, E.L. (1990) C5a-mediated release of interleukin 6 by human monocytes. Clin. Immunol. Immunopathol. 57, 297-307.
59. Scott, J.K., Duraikkannu, L., Blaine Easley, R., Gong, X. and Goldstein, I.J. (1992) A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89, 5398-5402.
60. Siciliano, S.J., Rollins, T.E., DeMartino, J., Konteatis, Z., Malkowitz, L., Van Riper, G., Bondy, S., Rosen, H. and Springer, M.S. (1994) Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 91, 1214-1218.
61. Tonnesen, M.G. (1989) Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J. Invest. Dermatol. 93, 53S-58S.